Glimmer of hope emerges in pilot trial of people with mild cognitive impairment ...

Memopezil is at the center of a rapidly growing conversation about cognitive health in 2026, as consumer interest in brain support has reached an all-time high, with search volume for terms like ...

Cognito Therapeutics, which is in late-stage development of its device to treat neurodegenerative diseases like Alzheimer’s, hauled in ...

Financing positions company for pivotal study data readout, FDA submission, and 2027 commercialization in Alzheimer’s diseaseCAMBRIDGE, Mass.--(BUSINESS WIRE)--#alzheimers--Cognito Therapeutics, a ...

A recent brain imaging study reveals that attention deficit hyperactivity disorder consists of at least two distinct physical subtypes. This discovery suggests that patients may eventually benefit ...

Cognito Therapeutics, a late clinical-stage neurotechnology company pioneering non-invasive neuroprotective therapies in neurodegenerative diseases, today announced the final close of its ...

The Massachusetts-based company will use the funds to advance its Spectris neurotechnology platform that uses visual and auditory stimulation to treat Alzheimer’s disease.

Most people think they're ruining their day at work. They're not. They're ruining it before they even get out of bed. The morning window is one of the most neurologically critical periods in your ...

Key points A 4-year-old boy presented to our urgent ophthalmology clinic for photophobia and persistent eye rubbing. He had been born at 39 weeks via Cesarean delivery, without complications. Prenatal ...

As people grow older, many parts of the body change, including sleep patterns and emotional health. Older adults often report that they sleep less deeply than they did when they were younger. At the ...

Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...